These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9601665)

  • 21. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I; Barrachina M; Puig B
    Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antigenic determinant properties of neurofibrillary tangles. Relevance to progressive supranuclear palsy.
    Cruz-Sánchez FF
    J Neural Transm Suppl; 1994; 42():165-78. PubMed ID: 7525867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early Stage of Progressive Supranuclear Palsy: A Neuropathological Study of 324 Consecutive Autopsy Cases.
    Nogami A; Yamazaki M; Saito Y; Hatsuta H; Sakiyama Y; Takao M; Kimura K; Murayama S
    J Nippon Med Sch; 2015; 82(6):266-73. PubMed ID: 26823029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical and ultrastructural characterization of neuritic clusters around ghost tangles in the hippocampal formation in progressive supranuclear palsy brains.
    Arima K; Nakamura M; Sunohara N; Nishio T; Ogawa M; Hirai S; Kawai M; Ikeda K
    Acta Neuropathol; 1999 Jun; 97(6):565-76. PubMed ID: 10378375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distribution of cortical neurofibrillary tangles in progressive supranuclear palsy: a quantitative analysis of six cases.
    Hof PR; Delacourte A; Bouras C
    Acta Neuropathol; 1992; 84(1):45-51. PubMed ID: 1502881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Up-regulation of Bcl-2 is associated with neuronal DNA damage in Alzheimer's disease.
    Su JH; Satou T; Anderson AJ; Cotman CW
    Neuroreport; 1996 Jan; 7(2):437-40. PubMed ID: 8730800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tau epitope display in progressive supranuclear palsy and corticobasal degeneration.
    Berry RW; Sweet AP; Clark FA; Lagalwar S; Lapin BR; Wang T; Topgi S; Guillozet-Bongaarts AL; Cochran EJ; Bigio EH; Binder LI
    J Neurocytol; 2004 May; 33(3):287-95. PubMed ID: 15475684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apolipoprotein E epsilon 4 allele frequency is not increased in progressive supranuclear palsy.
    Tabaton M; Rolleri M; Masturzo P; Cammarata S; Angelini G; Hansen LA; Saitoh T; Petersen RB; Perry G; Richey P
    Neurology; 1995 Sep; 45(9):1764-5. PubMed ID: 7675243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increase of cdk5 is related to neurofibrillary pathology in progressive supranuclear palsy.
    Borghi R; Giliberto L; Assini A; Delacourte A; Perry G; Smith MA; Strocchi P; Zaccheo D; Tabaton M
    Neurology; 2002 Feb; 58(4):589-92. PubMed ID: 11865137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Smad ubiquitination regulatory factor-2 in progressive supranuclear palsy.
    Nakamura M; Ito H; Nakamura Y; Wate R; Kaneko S; Nakano S; Matsumoto S; Kusaka H
    Neuropathol Appl Neurobiol; 2011 Apr; 37(3):307-14. PubMed ID: 20819168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression pattern of candidate cell death effector proteins Bax, Bcl-2, Bcl-X, and c-Jun in sensory and motor neurons following sciatic nerve transection in the rat.
    Gillardon F; Klimaschewski L; Wickert H; Krajewski S; Reed JC; Zimmermann M
    Brain Res; 1996 Nov; 739(1-2):244-50. PubMed ID: 8955944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipoperoxidation is selectively involved in progressive supranuclear palsy.
    Odetti P; Garibaldi S; Norese R; Angelini G; Marinelli L; Valentini S; Menini S; Traverso N; Zaccheo D; Siedlak S; Perry G; Smith MA; Tabaton M
    J Neuropathol Exp Neurol; 2000 May; 59(5):393-7. PubMed ID: 10888369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Temporal alterations in cellular Bax:Bcl-2 ratio following traumatic brain injury in the rat.
    Raghupathi R; Strauss KI; Zhang C; Krajewski S; Reed JC; McIntosh TK
    J Neurotrauma; 2003 May; 20(5):421-35. PubMed ID: 12803975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coexistence of PSP and MSA: a case report and review of the literature.
    Uchikado H; DelleDonne A; Uitti R; Dickson DW
    Acta Neuropathol; 2006 Feb; 111(2):186-92. PubMed ID: 16456665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bax expression in mammalian neurons undergoing apoptosis, and in Alzheimer's disease hippocampus.
    MacGibbon GA; Lawlor PA; Sirimanne ES; Walton MR; Connor B; Young D; Williams C; Gluckman P; Faull RL; Hughes P; Dragunow M
    Brain Res; 1997 Mar; 750(1-2):223-34. PubMed ID: 9098548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progressive supranuclear palsy affects both the substantia nigra pars compacta and reticulata.
    Hardman CD; Halliday GM; McRitchie DA; Cartwright HR; Morris JG
    Exp Neurol; 1997 Mar; 144(1):183-92. PubMed ID: 9126169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 4-repeat tauopathy sharing pathological and biochemical features of corticobasal degeneration and progressive supranuclear palsy.
    Katsuse O; Iseki E; Arai T; Akiyama H; Togo T; Uchikado H; Kato M; de Silva R; Lees A; Kosaka K
    Acta Neuropathol; 2003 Sep; 106(3):251-60. PubMed ID: 12802605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inferior olivary hypertrophy is uncommon in progressive supranuclear palsy.
    Katsuse O; Dickson DW
    Acta Neuropathol; 2004 Aug; 108(2):143-6. PubMed ID: 15235807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A qualitative and quantitative study of grumose degeneration in progressive supranuclear palsy.
    Ishizawa K; Lin WL; Tiseo P; Honer WG; Davies P; Dickson DW
    J Neuropathol Exp Neurol; 2000 Jun; 59(6):513-24. PubMed ID: 10850864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relationship between histopathological features of progressive supranuclear palsy and disease duration.
    Josephs KA; Mandrekar JN; Dickson DW
    Parkinsonism Relat Disord; 2006 Mar; 12(2):109-12. PubMed ID: 16337422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.